Cervical Cancer | Tumor

CURE’s cervical cancer page is an extensive resource of cancer information featuring the latest cervical cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on cervical cancer.

CURE's Top 5 Stories: January 2019

February 1st 2019, 7:00pm

Article

Here are the top 5 CURE stories for January 2019.

Patients With Gynecologic Cancers Want to Discuss Sexual Health

January 25th 2019, 10:56pm

Article

Nearly 90 percent of women experienced sexual dysfunction; however, providers were not openly communicating about this side effect, according to survey results.

Know the Facts: Cervical Cancer

January 11th 2019, 8:51pm

Article

In conjunction with Cervical Cancer Awareness Month, recognized in the month of January, here are some fast facts about the disease.

FDA Approves Age Expansion of HPV Vaccine

October 6th 2018, 1:05am

Article

The Food and Drug Administration (FDA) approved an expanded age indication for GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant), according to Merck, the manufacturer of the HPV vaccine.

Aromatherapy and Reflexology Drastically Reduce Pain, Anxiety in Cervical Cancer Treatment

October 4th 2018, 8:52pm

Article

Non-pharmacologic integrative medicine approaches such as aromatherapy and reflexology can dramatically reduce the pain and anxiety associated with cervical radiation therapy, according to a clinical study currently underway at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

FDA Grants Priority Review to GARDASIL 9 for Expanded Age Indication

June 13th 2018, 4:55pm

Article

The application is seeking approval for GARDASIL 9 to be used in women and men aged 27 to 45 years for the prevention of certain cancers and diseases caused by the nine human papillomavirus (HPV) types covered by the vaccine.

FDA Approves Keytruda To Treat Advanced, PD-L1-Positive Cervical Cancer

June 12th 2018, 11:56pm

Article

The Food and Drug Administration approved Keytruda (pembrolizumab) for the treatment of certain patients with cervical cancer.

FDA Grants Keytruda Priority Review for Cervical Cancer Treatment

March 13th 2018, 11:05pm

Article

Keytruda (pembrolizumab) was granted a priority review by the Food and Drug Administration (FDA) for the treatment of patients with advanced cervical cancer with disease progression or after chemotherapy.

NCCN Establishes Guidelines for Treating People With HIV and Cancer

February 27th 2018, 7:38pm

Article

Treatment of HIV has drastically improved since the 1980s, but many of these individuals are still facing barriers to proper cancer care.

FDA Approves Test to Identify Women with Increased Risk for Cervical Cancer

February 14th 2018, 1:30am

Article

This HPV-based test can help identify women who are at an increased risk for cervical cancer.